Daniel K. Reynolds

Randomized Pharmacokinetic and Pharmacodynamic Comparison of Fluoroquinolones for Tuberculous Meningitis

Guy Thwaites, Sujata M. Bhavnani, Tran Thi Hong Chau et al. · Antimicrobial Agents and Chemotherapy · 2011 · 137 citations · Full text

Intermediate Exposures, Pulmonary Tuberculosis, Antibiotics +14

Use of Pharmacokinetic-Pharmacodynamic Analyses To Optimize Therapy with the Systemic Antifungal Micafungin for Invasive Candidiasis or Candidemia

David R. Andes, Paul G. Ambrose, Jeffrey Hammel et al. · Antimicrobial Agents and Chemotherapy · 2011 · 118 citations · Full text

Mycological Response, Antifungal Agent, Pharmacokinetic-pharmacodynamic Analyses +15

Trends in Prevalence of Obesity and Overweight among Children Enrolled in the New York State WIC Program, 2002–2007

Jackson P. Sekhobo, Lynn S. Edmunds, Daniel K. Reynolds et al. · Public Health Reports · 2010 · 42 citations

Population pharmacokinetics of ceftaroline in patients with acute bacterial skin and skin structure infections or community‐acquired bacterial pneumonia

Scott A. Van Wart, Alan Forrest, Tatiana Khariton et al. · The Journal of Clinical Pharmacology · 2013 · 37 citations

Healthy Subjects, Klebsiella Pneumoniae, Pharmacotherapy +16

Clinical Pharmacodynamic Index Identification for Micafungin in Esophageal Candidiasis: Dosing Strategy Optimization

David R. Andes, Daniel K. Reynolds, Scott A. Van Wart et al. · Antimicrobial Agents and Chemotherapy · 2013 · 29 citations · Full text

Strategy Optimization, Pharmacotherapy, Daily Administration +17